BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18167534)

  • 1. Age-specific differences in oncogenic pathway deregulation seen in human breast tumors.
    Anders CK; Acharya CR; Hsu DS; Broadwater G; Garman K; Foekens JA; Zhang Y; Wang Y; Marcom K; Marks JR; Mukherjee S; Nevins JR; Blackwell KL; Potti A
    PLoS One; 2008 Jan; 3(1):e1373. PubMed ID: 18167534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.
    Anders CK; Hsu DS; Broadwater G; Acharya CR; Foekens JA; Zhang Y; Wang Y; Marcom PK; Marks JR; Febbo PG; Nevins JR; Potti A; Blackwell KL
    J Clin Oncol; 2008 Jul; 26(20):3324-30. PubMed ID: 18612148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia.
    Rao AV; Valk PJ; Metzeler KH; Acharya CR; Tuchman SA; Stevenson MM; Rizzieri DA; Delwel R; Buske C; Bohlander SK; Potti A; Löwenberg B
    J Clin Oncol; 2009 Nov; 27(33):5580-6. PubMed ID: 19858393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.
    Acharya CR; Hsu DS; Anders CK; Anguiano A; Salter KH; Walters KS; Redman RC; Tuchman SA; Moylan CA; Mukherjee S; Barry WT; Dressman HK; Ginsburg GS; Marcom KP; Garman KS; Lyman GH; Nevins JR; Potti A
    JAMA; 2008 Apr; 299(13):1574-87. PubMed ID: 18387932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age- and sex-specific genomic profiles in non-small cell lung cancer.
    Mostertz W; Stevenson M; Acharya C; Chan I; Walters K; Lamlertthon W; Barry W; Crawford J; Nevins J; Potti A
    JAMA; 2010 Feb; 303(6):535-43. PubMed ID: 20145230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.
    Azim HA; Michiels S; Bedard PL; Singhal SK; Criscitiello C; Ignatiadis M; Haibe-Kains B; Piccart MJ; Sotiriou C; Loi S
    Clin Cancer Res; 2012 Mar; 18(5):1341-51. PubMed ID: 22261811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
    Bild AH; Yao G; Chang JT; Wang Q; Potti A; Chasse D; Joshi MB; Harpole D; Lancaster JM; Berchuck A; Olson JA; Marks JR; Dressman HK; West M; Nevins JR
    Nature; 2006 Jan; 439(7074):353-7. PubMed ID: 16273092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
    Rodrigues NA; Dillon D; Carter D; Parisot N; Haffty BG
    Cancer; 2003 Mar; 97(6):1393-403. PubMed ID: 12627502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of breast cancer in young women.
    Azim HA; Partridge AH
    Breast Cancer Res; 2014 Aug; 16(4):427. PubMed ID: 25436920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.
    Rakha EA; Pinder SE; Paish EC; Robertson JF; Ellis IO
    J Pathol; 2004 Jul; 203(3):754-61. PubMed ID: 15221934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women.
    Kim J; Han W; Jung SY; Park YH; Moon HG; Ahn SK; Lee JW; Kim MK; Kim JJ; Lee ES; You TK; Kang HS; Lee ES; Ro J; Lee JE; Nam SJ; Yim YH; Park IA; Noh DY
    Ann Surg Oncol; 2015 Oct; 22(11):3481-8. PubMed ID: 25652052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
    Yau C; Fedele V; Roydasgupta R; Fridlyand J; Hubbard A; Gray JW; Chew K; Dairkee SH; Moore DH; Schittulli F; Tommasi S; Paradiso A; Albertson DG; Benz CC
    Breast Cancer Res; 2007; 9(5):R59. PubMed ID: 17850661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.
    Ahn SH; Son BH; Kim SW; Kim SI; Jeong J; Ko SS; Han W;
    J Clin Oncol; 2007 Jun; 25(17):2360-8. PubMed ID: 17515570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer.
    Dubsky PC; Gnant MF; Taucher S; Roka S; Kandioler D; Pichler-Gebhard B; Agstner I; Seifert M; Sevelda P; Jakesz R
    Clin Breast Cancer; 2002 Apr; 3(1):65-72. PubMed ID: 12020397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Younger women with breast carcinoma have a poorer prognosis than older women.
    Chung M; Chang HR; Bland KI; Wanebo HJ
    Cancer; 1996 Jan; 77(1):97-103. PubMed ID: 8630946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent Characteristics in Women with Breast Cancer: Mastectomy and Reconstructive Trends at an Urban Academic Institution.
    Rodby KA; Robinson E; Danielson KK; Quinn KP; Antony AK
    Am Surg; 2016 Mar; 82(3):227-35. PubMed ID: 27099059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
    Linardou H; Kalogeras KT; Kronenwett R; Alexopoulou Z; Wirtz RM; Zagouri F; Scopa CD; Gogas H; Petraki K; Christodoulou C; Pavlakis K; Koutras AK; Samantas E; Patsea H; Pectasides D; Bafaloukos D; Fountzilas G
    Anticancer Res; 2015 Jul; 35(7):4023-36. PubMed ID: 26124351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential association of BRCA1 and BRCA2 genes with some breast cancer-associated genes in early and late onset breast tumors.
    Chunder N; Mandal S; Roy A; Roychoudhury S; Panda CK
    Ann Surg Oncol; 2004 Dec; 11(12):1045-55. PubMed ID: 15576832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.